Akèy › Kansè Poumon ki pa ti selil › Minnesota › Bloomington
Etid klinik pou Kansè Poumon ki pa ti selil nan Bloomington, MN
10 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Bloomington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- ak 1 plis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Minnesota Oncology Hematology, P.A., Edina · 4 mi lwen
- Minnesota Oncology Hematology, PA, Burnsville · 5 mi lwen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Minnesota Oncology Hematology, P.A., Edina · 4 mi lwen
- Minnesota Oncology Hematology, P.A., Burnsville · 5 mi lwen
- Minnesota Oncology Hematology, P.A., Chaska · 15 mi lwen
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- M Health Fairview Cancer Clinic-Edina, Edina · 4 mi lwen
- Minnesota Oncology Hematology PA, Edina · 4 mi lwen
- Minnesota Oncology Hematology, PA, Burnsville · 5 mi lwen
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Ap rekriteFaz 2
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- ak 2 plis
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Ap rekriteFaz 2/3
- Local Institution - 007-589A, Edina · 4 mi lwen
- USOR - Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Fairview Southdale Hospital, Edina · 4 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Fairview Southdale Hospital, Edina · 4 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- Saint Francis Regional Medical Center, Shakopee · 12 mi lwen
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY121 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH57 etid
- Washington, DC55 etid
Lòt etid nan Bloomington
- Kansè poumon10 etid
- Kansè kolorektal7 etid
- Kansè pwostat6 etid
- Leksemi mieloïd egi6 etid
- Kansè renn (Kasinom selil renn)6 etid
- Kansè vejik5 etid
- Kansè nan tete5 etid
- Kansè Endomèt4 etid
- Kansè kolon4 etid
- Melanom4 etid
- Kansè lestomak3 etid
- Kansè Ezofajyen3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.